G-4199 Gemcitabine, Free Base, >99%

Synonyms : [dFdC] [dFdCyd] [LY-188011]

Related Terms : [Gamcitabine] [Gemcitera] [Gemsar] [Gemzar] [Zefei]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 100 mg
  • 39
  • 34
  • 30
  • 4,300
  • Add to Cart Qty:
  • In stock
  • 300 mg
  • 49
  • 43
  • 38
  • 5,500
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 69
  • 61
  • 53
  • 7,700
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 95
  • 84
  • 74
  • 10,600
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 158
  • 141
  • 123
  • 17,600
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 295
  • 263
  • 230
  • 32,800
  • Add to Cart Qty:
  • In stock
  • 10 g
  • 430
  • 383
  • 335
  • 47,900
  • Add to Cart Qty:
  • In stock
  • 25 g
  • 790
  • 705
  • 616
  • 87,900
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Click Here to see what Shipping and Handling Costs would be to Your Country
  • M.W. 263.20
  • C9H11F2N3O4
  • [95058-81-4]
  • M.I. 14: 4386

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 65 mg/mL; soluble in ethanol at 12 mg/mL with slight warming; soluble in water at 15 mg/mL with slight warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.

Certificate of Analysis

  • This is the free base form of gemcitabine; please see the other form of this product, Gemcitabine, Hydrochloride Salt, Cat. No. G-4177, for further technical information. The hydrochloride salt form is used for some or all of the formulations of gemcitabine for in vivo use.
  • Gemcitabine (as the hydrochloride salt) is the active ingredient in drug products sold under numerous trade names listed near the top of this page as "Related Terms". These drug products have been approved in at least one country to be used alone or in combination with other medicines to treat breast cancer, ovarian cancer, non-small cell lung cancer, and cancer of the pancreas. NOTE: THE GEMCITABINE, FREE BASE RESEARCH COMPOUND SOLD BY LC LABORATORIES IS NOT ANY OF THE GEMCITABINE-CONTAINING DRUG PRODUCTS SOLD UNDER VARIOUS TRADE NAMES AND IS NOT FOR HUMAN USE.
  • NOTE: the trade names listed above under "Related Terms" are for gemcitabine-containing drug products and may apply variously to formulations of one or another form of gemcitabine, such as the free base, hydrochloride salt or other salt form.
  • This gemcitabine product is the free base, whose CAS number is given above. The CAS number of the hydrochloride salt is 122111-03-9.
  • Another CAS number previously assigned to gemcitabine free base, namely 1239668-67-7, has been deleted by CAS and is no longer in use.
  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.
130